| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $19K | -87.4% |
| R&D Expense | $5.7M | -51.4% |
| SG&A Expense | $6.1M | -14.0% |
| Operating Income | -$11.8M | +36.9% |
| Net Income | -$7.4M | +60.5% |
| EPS (Basic) | -$11.35 | +37.4% |
| EPS (Diluted) | -$11.35 | +37.4% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $149K | -93.4% |
| Current Assets | $2.1M | -55.3% |
| Total Assets | $2.8M | -49.0% |
| Current Liabilities | $3.2M | -41.9% |
| Total Liabilities | $3.3M | -42.4% |
| Stockholders' Equity | -$486K | -114.9% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.6M | +59.7% |
| Investing Cash Flow | -$12K | +97.3% |
| Financing Cash Flow | $6.5M | -69.1% |